Aquiline Capital Partners (Aquiline), a private investment firm with over $10bn in AUM, has made a majority investment in PharmaForce, a pharmacy solutions provider to hospitals and health clinics. Financial terms of the deal have not been disclosed.
The provider has delivered 340B administration software to over 280 clients since its inception in 2017 and recently launched a pharmacy benefits management offering.
In a press statement, PharmaForce said that, with Aquiline’s backing, it will “accelerate strategic M&A and continue to expand its product capabilities”.
Get the week’s top news delivered directly to your inbox – Sign up for our newsletter
Piper Sandler served as financial advisor to PharmaForce. Legal counsel was provided by Taft and Ropes & Gray to PharmaForce and Aquiline respectively.
Source: Private Equity Wire
Can’t stop reading? Read more
Eldridge and Arctos unveil retail vehicle giving investors a stake in elite sports and media
Eldridge and Arctos unveil retail vehicle giving investors a stake in elite sports and media...
Blue Owl raises $1.7bn for digital infrastructure trust as data centre demand accelerates
Blue Owl raises $1.7bn for digital infrastructure trust as data centre demand accelerates Blue Owl...
Lone Star nears $4.5bn exit as ITT advances talks to buy SPX Flow
Lone Star nears $4.5bn exit as ITT advances talks to buy SPX Flow ITT is in advanced negotiations...